A. von Deimling

Discipline

Psychologie (1)

Type de document

Articles (6) Recensions (1)

Co-auteur

Date

Source

Mot-clé

Patients (6) Patients (6) survie (5) Treatment (5) Survival (5) Methylation (5) Methylation (5) ADN (4) procès (4) Tumors (4) Prognosis (4) DNA (4) Prognosis (4) analyse (3) adulte (3) Radiotherapy (3) Manufacturers' agents (3) Commission merchants (3) Clinical trials (3) Chemotherapy (3) Analysis (3) Tumors (3) Radiotherapy (3) adulte (3) tumeur (2) thérapie (2) qualité de vie (2) association (2) mutation (2) gène (2)

Documents écrit par A. von Deimling (6) | parle de A. von Deimling (0)

DNA methylation-based age acceleration observed in IDH wild-type glioblastoma is associated with better outcome-including in elderly patients.
P. Bady et al. (24 mars 2022)
Oligosarcomas, IDH-mutant are distinct and aggressive.
A.K. Suwala et al.
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood.
M. Weller et al.
The DNA methylome of DDR genes and benefit from RT or TMZ in IDH mutant low-grade glioma treated in EORTC 22033.
P. Bady et al.
Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study.
B.G. Baumert et al. (2016)
Presence of an oligodendroglioma-like component in newly diagnosed glioblastoma identifies a pathogenetically heterogeneous subgroup and lacks prognostic value: central pathology review of the EORTC_26981/NCIC_CE.3 trial.
M.E. Hegi et al. (2012)